Teva-Levocarbidopa (2018-01-17)
- Starting date:
- January 17, 2018
- Posting date:
- January 17, 2018
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-65866
Affected Products
Teva-Levocarbidopa
Reason
Out-of-specification on dissolution during stability testing.
Depth of distribution
Product has been distributed to retail level across the Canadian provinces: AB, BC, MB, NL, NS, ON, QC and SK.
Affected products
Teva-Levocarbidopa
DIN, NPN, DIN-HIM
DIN 02244496
Dosage form
Tablet
Strength
250mg/ 25mg
Lot or serial number
- Lot 35211134B
- Lot 35211134C
Companies
- Recalling Firm
-
Teva Canada Limited 30 Novopharm Court Toronto, ON M1B 2K9
- Marketing Authorization Holder
-
Teva Canada Limited 30 Novopharm Court Toronto, ON M1B 2K9